Katherine Payne

Katherine Payne is Professor of Health Economics at The University of Manchester's Faculty of Biology, Medicine and Health, specifically within the Division of Population Health, Health Services Research & Primary Care. She leads the Manchester Centre for Health Economics and serves as Deputy Director of her division since May 2023. Her research bridges applied and methodological health economics with a focus on precision medicine and genomic technologies.

• Education:
  • PhD in Pharmacy Practice (Manchester, 2000)
  • MSc in Health Economics (York, 1994)
  • Diploma in Clinical Pharmacy (Keel, 1992)
  • BPharm (Bath, 1989)

Her scholarly work emphasizes economic evaluation of healthcare interventions using RCTs and decision-analytic models, alongside valuation methods like discrete choice experiments. Current projects analyze precision prevention strategies for chronic diseases (liver, breast cancer) and pharmacogenetic applications in autoimmune conditions (rheumatoid arthritis, lupus).

Recent publications demonstrate methodological innovations in non-health benefit valuation and resource allocation for genomic services. She has contributed to large-scale MRC-funded consortia and developed the MANC-RISK-SCREEN tool for stratified screening. Her work aligns with UN Sustainable Development Goals related to health equity and planetary well-being.

• Scientific Recognition:
  • AACR Team Science Award (2024)
  • NIHR Senior Investigator (2023)
  • RCUK Academic Fellowship (2007)

She actively shapes policy as a member of the UK National Screening Committee Research Group and previously served on NICE Technology Appraisal Committees. Her leadership extends to organizing international forums on personalized preventative healthcare and chairing HTAi meetings in Manchester.